Close Menu
September 09, 2020
Sponsored by
10x Genomics

Spatially Resolved Transcriptomics: The Landscape of Tools for Spatial Gene Expression


Science for Life Laboratory, KTH Royal Institute Technology

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems. The importance of spatial context to infer deeper biological meaning is unquestionable, but technological constraints have historically limited broad adoption for various applications.

The field has quickly expanded in recent years, and several new technologies have been developed that aim to combine gene expression data with spatial information. The vast array of methodologies displays fundamental differences in their approach to obtain this information and, thus, demonstrate method-specific advantages and shortcomings. Nevertheless, the field of spatially resolved transcriptomics is accelerating in technological advancement, and the many biological analyses made possible by this advancement are just beginning to be fully explored.

In this webinar sponsored by 10x Genomics, Dr. Joakim Lundeberg of the KTH Royal Institute of Technology will present: 

  • A historical timeline of spatial gene expression methods
  • The current landscape of spatial transcriptomic methods as well as their strengths and weaknesses
  • Applications of spatial transcriptomics in a broad spectrum of research areas, including oncology, immunology, and neuroscience 
  • Future developments in spatially resolved transcriptomics and where the field is heading
Sponsored by

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

Sponsored by
Foundation Medicine

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Sponsored by

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Sponsored by

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

Sponsored by
Mission Bio

This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.